litlas
Log inCreate account

David G. Warnock

Active 1979–2024

111
Papers
27,843
Citations
87
h-index
111
i10-index

Citations

Citations per year for David G. Warnock1981: 5 citations1982: 2 citations1983: 14 citations1984: 6 citations1985: 15 citations1986: 11 citations1987: 14 citations1988: 12 citations1989: 9 citations1990: 9 citations1991: 7 citations1992: 4 citations1993: 7 citations1994: 6 citations1995: 22 citations1996: 34 citations1997: 41 citations1998: 43 citations1999: 60 citations2000: 61 citations2001: 56 citations2002: 56 citations2003: 64 citations2004: 81 citations2005: 71 citations2006: 60 citations2007: 105 citations2008: 173 citations2009: 192 citations2010: 206 citations2011: 235 citations2012: 316 citations2013: 315 citations2014: 296 citations2015: 261 citations2016: 288 citations2017: 223 citations2018: 210 citations2019: 779 citations2020: 797 citations2021: 729 citations2022: 498 citations2023: 358 citations2024: 572 citations2025: 277 citations2026: 2 citations2027: 1 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,781 citing papers, 26% of this breakdownUnited Kingdom: 754 citing papers, 7.1% of this breakdownChina: 686 citing papers, 6.4% of this breakdownGermany: 577 citing papers, 5.4% of this breakdownItaly: 557 citing papers, 5.2% of this breakdownCanada: 527 citing papers, 4.9% of this breakdownFrance: 380 citing papers, 3.6% of this breakdownAustralia: 374 citing papers, 3.5% of this breakdownJapan: 328 citing papers, 3.1% of this breakdownSpain: 309 citing papers, 2.9% of this breakdownNetherlands: 299 citing papers, 2.8% of this breakdownSwitzerland: 262 citing papers, 2.4% of this breakdown
0%26%Other 26.7%

Institutions

Fields

  • Medicine76.4%
  • Biochemistry, Genetics and Molecular Biology17.7%
  • Nursing1.2%
  • Immunology and Microbiology0.9%
  • Health Professions0.6%
  • Environmental Science0.5%
  • Other2.7%

Topics

  • Acute Kidney Injury Research9.2%
  • Chronic Kidney Disease and Diabetes7.8%
  • Dialysis and Renal Disease Management5.1%
  • Ion Transport and Channel Regulation3.1%
  • Lysosomal Storage Disorders Research2.7%
  • Trauma, Hemostasis, Coagulopathy, Resuscitation2.5%
  • Other69.6%

Coauthors

All papers

Open in search
  1. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

    Authors: Ravindra L. Mehta, John A. Kellum, Sudhir V. Shah, Bruce A. Molitoris, Claudio Ronco, David G. Warnock, Adeera Levin, the Acute Kidney Injury Network - Critical Care 2007 cited by 7,080

  2. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data

    Authors: Kunihiro Matsushita, Josef Coresh, Yingying Sang, John Chalmers, Caroline S. Fox, Eliseo Güallar, Tazeen H. Jafar, Simerjot K Jassal, Gijs W.D. Landman, Paul Muntner, Paul Roderick, Toshimi Sairenchi, Ben Schöttker, Anoop Shankar, Michael G. Shlipak, Marcello Tonelli, John Townend, Arjan van Zuilen, Kazumasa Yamagishi, Kentaro Yamashita, Ron T. Gansevoort, Mark J. Sarnak, David G. Warnock, Mark Woodward, Johan Ärnlöv - The Lancet Diabetes & Endocrinology 2015 cited by 897

  3. The global burden of chronic kidney disease: estimates, variability and pitfalls

    Authors: Richard J. Glassock, David G. Warnock, Pierre Delanaye - Nature Reviews Nephrology 2016 cited by 510

  4. Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes

    Authors: Pablo E. Pérgola, Philip Raskin, Robert D. Toto, Colin J. Meyer, Jesse W. Huff, Eric Grossman, Melissa Krauth, Stacey Ruiz, Paul Audhya, Heidi Christ‐Schmidt, Janet Wittes, David G. Warnock - New England Journal of Medicine 2011 cited by 876

  5. Comparison of Risk Prediction Using the CKD-EPI Equation and the MDRD Study Equation for Estimated Glomerular Filtration Rate

    Authors: Kunihiro Matsushita, Bakhtawar K. Mahmoodi, Mark Woodward, Jonathan Emberson, Tazeen H. Jafar, Sun Ha Jee, Kevan R. Polkinghorne, Anoop Shankar, David H. Smith, Marcello Tonelli, David G. Warnock, Chi-Pang Wen, Josef Coresh, Ron T. Gansevoort, Brenda R. Hemmelgarn, Andrew S. Levey - JAMA 2012 cited by 991

  6. Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study

    Authors: Eric Wallace, Özlem Göker-Alpan, William R. Wilcox, Myrl Holida, John Bernat, Nicola Longo, Aleš Linhart, Derralynn Hughes, Robert J. Hopkin, Camilla Tøndel, Mirjam Langeveld, Pilar Giraldo, Antonio Pisani, Dominique P. Germain, Ankit Mehta, Patrick Deegan, Mária Judit Molnár, Damara Ortiz, Ana Jovanović, Michael Muriello, Bruce A. Barshop, Virginia Kimonis, Bojan Vujkovac, Albina Nowak, Tarekegn Geberhiwot, Ilkka Kantola, Jasmine Knoll, Stephen Waldek, Khan Nedd, Amel Karaa, Einat Brill‐Almon, Sari Alon, Raul Chertkoff, Rossana Rocco, Anat Sakov, David G. Warnock - Journal of Medical Genetics 2023 cited by 43

  7. Acute Kidney Injury and Mortality in Hospitalized Patients

    Authors: Henry E. Wang, Paul Muntner, Glenn M. Chertow, David G. Warnock - American Journal of Nephrology 2012 cited by 543

  8. A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury

    Authors: Matthew T. James, Morgan E. Grams, Mark Woodward, C. Raina Elley, Jamie A. Green, David C. Wheeler, Paul de Jong, Ron T. Gansevoort, Andrew S. Levey, David G. Warnock, Mark J. Sarnak, Marcello Tonelli, Brenda R. Hemmelgarn, Matthew T. James, Tanvir Chowdhury Turin, Josef Coresh, Kunihiro Matsushita, Morgan E. Grams, Yingying Sang, Michael G. Shlipak, Mark J. Sarnak, Ronit Katz, David C. Wheeler, Jonathan Emberson, Martin Landray, John Townend, Jamie Green, Henriette Kirchner, Robert M. Perkins, Alex R. Chang, Solfrid Romundstad, Knut Aasarød, Cecilia Montgomery Øien, Stein Hallan, David H. Smith, Micah L. Thorp, Eric S. Johnson, Gabriel Chodick, Esma Herzel, Rachel Katz, Varda Shalev, Ron T. Gansevoort, Stephan J. L. Bakker, Hiddo J. Lambers Heerspink, Pim van der Harst, Sun Ha Jee, Heejin Kimm, Yejin Mok, Navdeep Tangri, David Naimark, Johan Ärnlöv, Anders Larsson, Lars Lannfelt, Csaba P. Kövesdy, Kamyar Kalantar‐Zadeh, Josef Coresh, Morgan E. Grams, Kunihiro Matsushita, Ron T. Gansevoort, Paul E. de Jong, Kunitoshi Iseki, Andrew S. Levey, Mark J. Sarnak, Bénédicte Stengel, David G. Warnock, Mark Woodward, Shoshana H. Ballew, Josef Coresh, Morgan E. Grams, Kunihiro Matsushita, Yingying Sang, Mark Woodward - American Journal of Kidney Diseases 2015 cited by 309

  9. Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease

    Authors: Dominique P. Germain, Joel Charrow, Robert J. Desnick, Nathalie Guffon, Judy Kempf, Robin Lachmann, Roberta Lemay, Gabor E. Linthorst, Seymour Packman, C. Ronald Scott, Stephen Waldek, David G. Warnock, Neal J. Weinreb, William R. Wilcox - Journal of Medical Genetics 2015 cited by 364

  10. Global Cardiovascular and Renal Outcomes of Reduced GFR

    Authors: Bernadette Thomas, Kunihiro Matsushita, Kalkidan Hassen Abate, Ziyad Al-Aly, Johan Ärnlöv, Kei Asayama, Robert Atkins, Alaa Badawi, Shoshana H. Ballew, Amitava Banerjee, Lars Barregård, Elizabeth Barrett-Connor, Sanjay Basu, Aminu K. Bello, Isabela Bensenor, Jaclyn Bergstrom, Boris Bikbov, Christopher Blosser, Hermann Brenner, Juan-Jesus Carrero, Steve Chadban, Massimo Cirillo, Monica Cortinovis, Karen Courville, Lalit Dandona, Rakhi Dandona, Kara Estep, João Fernandes, Florian Fischer, Caroline Fox, Ron T. Gansevoort, Philimon N. Gona, Orlando M. Gutierrez, Samer Hamidi, Sarah Wulf Hanson, Jonathan Himmelfarb, Simerjot K. Jassal, Sun Ha Jee, Vivekanand Jha, Aida Jimenez-Corona, Jost B. Jonas, Andre Pascal Kengne, Yousef Khader, Young-Ho Khang, Yun Jin Kim, Barbara Klein, Ronald Klein, Yoshihiro Kokubo, Dhaval Kolte, Kristine Lee, Andrew S. Levey, Yongmei Li, Paulo Lotufo, Hassan Magdy Abd El Razek, Walter Mendoza, Hirohito Metoki, Yejin Mok, Isao Muraki, Paul M. Muntner, Hiroyuki Noda, Takayoshi Ohkubo, Alberto Ortiz, Norberto Perico, Kevan Polkinghorne, Rajaa Al-Radaddi, Giuseppe Remuzzi, Gregory Roth, Dietrich Rothenbacher, Michihiro Satoh, Kai-Uwe Saum, Monika Sawhney, Ben Schöttker, Anoop Shankar, Michael Shlipak, Diego Augusto Santos Silva, Hideaki Toyoshima, Kingsley Ukwaja, Mitsumasa Umesawa, Stein Emil Vollset, David G. Warnock, Andrea Werdecker, Kazumasa Yamagishi, Yuichiro Yano, Naohiro Yonemoto, Maysaa El Sayed Zaki, Mohsen Naghavi, Mohammad H. Forouzanfar, Christopher J.L. Murray, Josef Coresh, Theo Vos, on behalf of the Global Burden of Disease 2013 GFR Collaborators, Global Burden of Disease Genitourinary Expert Group - Journal of the American Society of Nephrology 2017 cited by 275

  11. Kidney Function and Cognitive Impairment in US Adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study

    Authors: Manjula Kurella Tamura, Virginia G. Wadley, Kristine Yaffe, Leslie A. McClure, George Howard, Rodney C.P. Go, Richard M. Allman, David G. Warnock, William McClellan - American Journal of Kidney Diseases 2008 cited by 385

  12. Agalsidase-Beta Therapy for Advanced Fabry Disease

    Authors: Maryam Banikazemi, Jan Bultas, Stephen Waldek, William R. Wilcox, Chester B. Whitley, Timothy J. McDonald, Richard S. Finkel, Seymour Packman, Daniel G. Bichet, David G. Warnock, Robert J. Desnick - Annals of Internal Medicine 2007 cited by 566

  13. A new approach to identifying patients with elevated risk for Fabry disease using a machine learning algorithm

    Authors: John L. Jefferies, Alison K. Spencer, Heather Lau, Matthew W. Nelson, Joseph Giuliano, Joseph W. Zabinski, Costas Boussios, Gary C. Curhan, Richard E Gliklich, David G. Warnock - Orphanet Journal of Rare Diseases 2021 cited by 46

  14. Screening, diagnosis, and management of patients with Fabry disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

    Authors: Raphael Schiffmann, Derralynn Hughes, Gabor E. Linthorst, Alberto Ortíz, Einar Svarstad, David G. Warnock, Michael L. West, Christoph Wanner, Daniel G. Bichet, Erik Christensen, Ricardo Correa‐Rotter, Perry Elliott, Sandro Feriozzi, Agnes B. Fogo, Dominique P. Germain, Carla E. M. Hollak, Robert J. Hopkin, Jack Johnson, Ilkka Kantola, Jeffrey B. Kopp, Jürgen Kröner, Aleš Linhart, Ana María Martins, Dietrich Matern, Atul Mehta, Renzo Mignani, Behzad Najafian, Ichiei Narita, Kathy Nicholls, Greg T. Obrador, João Paulo Oliveira, Antonio Pisani, Juan Politei, Uma Ramaswami, Markus Ries, Wim Terryn, Camilla Tøndel, Roser Torrá, Bojan Vujkovac, Stephen Waldek, Jerry Walter - Kidney International 2016 cited by 188

  15. Design of Clinical Trials in Acute Kidney Injury

    Authors: Paul M. Palevsky, Bruce A. Molitoris, Mark D. Okusa, Adeera Levin, Sushrut S. Waikar, Ron Wald, Glenn M. Chertow, Patrick Murray, Chirag R. Parikh, Andrew Shaw, Alan S. Go, Sarah Faubel, John A. Kellum, Vernon M. Chinchilli, Kathleen D. Liu, Alfred K. Cheung, Steven D. Weisbord, Lakhmir S. Chawla, James S. Kaufman, Prasad Devarajan, Robert Toto, Chi‐yuan Hsu, Tom Greene, Ravindra L. Mehta, John B. Stokes, Aliza M. Thompson, Bruce Thompson, Christof Westenfelder, James A. Tumlin, David G. Warnock, Sudhir V. Shah, Yining Xie, Emily G. Duggan, Paul L. Kimmel, Robert A. Star - Clinical Journal of the American Society of Nephrology 2012 cited by 188

  16. Global Cardiovascular and Renal Outcomes of Reduced GFR

    Authors: Thomas, B, Kunihiro Matsushita, Kalkidan Hassen Abate, Ziyad Al‐Aly, Amlov, J, Kei Asayama, Robert C. Atkins, Alaa Badawi, Shoshana H. Ballew, Amitava Banerjee, Lars Barregård, Elizabeth Barrett‐Connor, Sanjay Basu, Aminu K. Bello, Isabela M. Benseñor, Jaclyn Bergstrom, Boris Bikbov, Christopher D. Blosser, Hermann Brenner, Juan Jesús Carrero, Steven J. Chadban, Massimo Círillo, Monica Cortinovis, Karen Courville, Lalit Dandona, Rakhi Dandona, Kara Estep, João Carlos Fernandes, Florian Fischer, Caroline S. Fox, Ron T. Gansevoort, Philimon Gona, Orlando M. Gutiérrez, Samer Hamidi, Sarah Wulf Hanson, Jonathan Himmelfarb, Simerjot K Jassal, Sun Ha Jee, Vivekanand Jha, Aída Jiménez-Corona, Jost B. Jonas, André Pascal Kengne, Yousef Khader, Young‐Ho Khang, Yun Jin Kim, Barbara E.K. Klein, Ronald Klein, Yoshihiro Kokubo, Dhaval Kolte, Kristine Lee, Andrew S. Levey, Yongmei Li, Paulo A. Lotufo, Hassan Magdy Abd El Razek, Walter Mendoza, Hirohito Metoki, Yejin Mok, Isao Muraki, Paul Muntner, Hiroyuki Noda, Takayoshi Ohkubo, Alberto Ortíz, Norberto Perico, Kevan R. Polkinghorne, Rajaa Al-Radaddi, Giuseppe Remuzzi, Gregory A. Roth, Dietrich Rothenbacher, Michihiro Satoh, Kai‐Uwe Saum, Monika Sawhney, Schoettker, B, Anoop Shankar, Michael Shlipak, Diego Augusto Santos Silva, Hideaki Toyoshima, Kingsley Nnanna Ukwaja, Mitsumasa Umesawa, Vollset, SE, David G. Warnock, Andrea Werdecker, Kazumasa Yamagishi, Yuichiro Yano, Naohiro Yonemoto, Maysaa El Sayed Zaki, Mohsen Naghavi, Mohammad H. Forouzanfar, Christopher J L Murray, Josef Coresh, Theo Vos - 2017 cited by 184

  17. Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry

    Authors: Alberto Ortíz, Ademola K. Abiose, Daniel G. Bichet, Gustavo Cabrera, Joel Charrow, Dominique P. Germain, Robert J. Hopkin, Ana Jovanović, Aleš Linhart, Sonia S. Maruti, Michael Mauer, João Paulo Oliveira, Manesh R. Patel, Juan Politei, Stephen Waldek, Christoph Wanner, Han‐Wook Yoo, David G. Warnock - Journal of Medical Genetics 2016 cited by 147

  18. Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry

    Authors: William R. Wilcox, João Paulo Oliveira, Robert J. Hopkin, Alberto Ortíz, Maryam Banikazemi, Ulla Feldt‐Rasmussen, Katherine B. Sims, Stephen Waldek, Gregory M. Pastores, Philip Lee, Christine M. Eng, László Maródi, Kevin E. Stanford, Frank Breunig, Christoph Wanner, David G. Warnock, Roberta Lemay, Dominique P. Germain - Molecular Genetics and Metabolism 2007 cited by 539

  19. Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy

    Authors: Raphael Schiffmann, David G. Warnock, Maryam Banikazemi, Jan Bultas, Gabor E. Linthorst, Seymour Packman, S. A. Sørensen, William R. Wilcox, Robert J. Desnick - Nephrology Dialysis Transplantation 2009 cited by 366

  20. A Meta-analysis of the Association of Estimated GFR, Albuminuria, Age, Race, and Sex With Acute Kidney Injury

    Authors: Morgan E. Grams, Yingying Sang, Shoshana H. Ballew, Ron T. Gansevoort, Heejin Kimm, Csaba P. Kövesdy, David Naimark, Cecilia Montgomery Øien, David H. Smith, Josef Coresh, Mark J. Sarnak, Bénédicte Stengel, Marcello Tonelli, Marcello Tonelli, Brenda R. Hemmelgarn, Matthew T. James, Tanvir Chowdhury Turin, Josef Coresh, Kunihiro Matsushita, Morgan E. Grams, Yingying Sang, Michael G. Shlipak, Mark J. Sarnak, Ronit Katz, David C. Wheeler, Jonathan Emberson, Martin Landray, John Townend, Jamie Green, Henriette Kirchner, Robert M. Perkins, Alex R. Chang, Solfrid Romundstad, Knut Aasarød, Cecilia Montgomery Øien, Stein Hallan, David H. Smith, Micah L. Thorp, Eric S. Johnson, Gabriel Chodick, Esma Herzel, Rachel Katz, Varda Shalev, Ron T. Gansevoort, Stephan J. L. Bakker, Hiddo J.L. Heerspink, Pim van der Harst, Sun Ha Jee, Heejin Kimm, Yejin Mok, Navdeep Tangri, David Naimark, Johan Ärnlöv, Anders Larsson, Lars Lannfelt, Csaba P. Kövesdy, Kamyar Kalantar‐Zadeh, Josef Coresh, Morgan E. Grams, Kunihiro Matsushita, Ron T. Gansevoort, Paul E. de Jong, Kunitoshi Iseki, Andrew S. Levey, Mark J. Sarnak, Bénédicte Stengel, David G. Warnock, Mark Woodward, Shoshana H. Ballew, Josef Coresh, Morgan E. Grams, Kunihiro Matsushita, Yingying Sang, Mark Woodward - American Journal of Kidney Diseases 2015 cited by 225

  21. Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study

    Authors: Melanie Chin, George L. Bakris, Geoffrey A. Block, Glenn M. Chertow, Angie Goldsberry, Lesley A. Inker, Hiddo J.L. Heerspink, Megan O’Grady, Pablo E. Pérgola, Christoph Wanner, David G. Warnock, Colin J. Meyer - American Journal of Nephrology 2018 cited by 161

  22. Liddle's syndrome: Heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel

    Authors: Richard A. Shimkets, David G. Warnock, Christopher M. Bositis, Carol Nelson‐Williams, Joni H. Hansson, Morris Schambelan, John R. Gill, Stanley Ulick, Robert V. Milora, James W. Findling, Cecilia M. Canessa, Bernard C. Rossier, Richard P. Lifton - Cell 1994 cited by 1,264

  23. Fabry disease: Guidelines for the evaluation and management of multi-organ system involvement

    Authors: Christine M. Eng, Dominique P. Germain, Maryam Banikazemi, David G. Warnock, Christoph Wanner, Robert J. Hopkin, Jan Bultas, Philip Lee, Katherine B. Sims, Scott E. Brodie, Gregory M. Pastores, Joerg Strotmann, William R. Wilcox - Genetics in Medicine 2006 cited by 417

  24. Lyso-Gb3 associates with adverse long-term outcome in patients with Fabry disease

    Authors: Albina Nowak, Felix Beuschlein, Visnuka Sivasubramaniam, David C. Kasper, David G. Warnock - Journal of Medical Genetics 2021 cited by 66